OPPENHEIMER & CO INC - TRANSMEDICS GROUP INC ownership

TRANSMEDICS GROUP INC's ticker is TMDX and the CUSIP is 89377M109. A total of 135 filers reported holding TRANSMEDICS GROUP INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
OPPENHEIMER & CO INC ownership history of TRANSMEDICS GROUP INC
ValueSharesWeighting
Q3 2023$492,257
-53.4%
8,991
-28.6%
0.01%
-52.4%
Q2 2023$1,057,308
+22.2%
12,590
+10.2%
0.02%
+16.7%
Q1 2023$865,442
+42.7%
11,428
+16.3%
0.02%
+28.6%
Q4 2022$606,461
+16.0%
9,826
-21.5%
0.01%
+16.7%
Q3 2022$523,000
+74.3%
12,521
+31.2%
0.01%
+100.0%
Q2 2022$300,000
+16.7%
9,5400.0%0.01%
+20.0%
Q1 2022$257,0009,5400.01%
Other shareholders
TRANSMEDICS GROUP INC shareholders Q2 2022
NameSharesValueWeighting ↓
Roubaix Capital, LLC 264,438$5,027,0004.84%
Abrams Capital Management 3,499,859$66,532,0002.07%
Sandhill Capital Partners LLC 736,175$13,995,0001.55%
EMERALD ADVISERS, LLC 451,542$8,584,0000.36%
RTW INVESTMENTS, LP 503,266$9,567,0000.36%
EMERALD MUTUAL FUND ADVISERS TRUST 429,868$8,172,0000.33%
NEXT CENTURY GROWTH INVESTORS LLC 107,045$2,034,0000.26%
ELEMENT CAPITAL MANAGEMENT LLC 63,175$1,201,0000.26%
HAMILTON LANE ADVISORS LLC 19,364$368,0000.16%
Harbour Capital Advisors, LLC 20,900$397,0000.15%
View complete list of TRANSMEDICS GROUP INC shareholders